A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
Ottawa Citizen on MSN
Approval of new Alzheimer's drug in Canada called historic
The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...
On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...
A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...
Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
The 39-year-old from Hull lost his dad from Familial Alzheimer's disease (FAD) when he was a child and knew he had a 50:50 ...
Daily Times on MSN
Alzheimer's disease - the pause in life
Have you ever forgotten something so simple and mundane like what you ate the other day repeatedly? If the answer is yes, ...
While drugs can help manage symptoms, there is currently no cure for Lewy Body Dementia. Despite the challenges, Kent has ...
Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...
Veteran actor Satish Shah passed away at 74 due to kidney failure. The actor had earlier undergone a kidney transplant to ...
The Canadian Press on MSN
Health Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease
TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease. Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback